Johnson & Johnson Elects JPMorganChase President Daniel Pinto to Board of Directors

Daniel Pinto, President, JPMorganChase • Photo Credit: Johnson & Johnson

Corporate Business News Sponsored by VS News Network

NEW BRUNSWICK, N.J., May 21, 2025 (BUSINESS WATCH GLOBAL) — Healthcare company Johnson & Johnson has announced the election of Daniel Pinto, President of JPMorganChase, to its Board of Directors.

Pinto brings over three decades of financial leadership experience, currently serving as President and a member of the Operating Committee at JPMorganChase. He will remain in this role until June 30, 2025, before transitioning to Vice Chairman through the end of 2026.

"Daniel’s unique perspective and wealth of experience will be a tremendous asset to Johnson & Johnson as we continue to invest in and advance the next generation of healthcare innovation for patients," said Joaquin Duato, Chairman and Chief Executive Officer of Johnson & Johnson.

“It’s an honor to join Johnson & Johnson’s board of directors and serve alongside board members who are dedicated to improving the health and well-being of communities around the world,” said Pinto.

Pinto joined JPMorganChase’s predecessor company in 1983 as a financial analyst and foreign exchange trader in Buenos Aires. He later held several roles, including global head of Emerging Markets, CEO of the Corporate & Investment Bank, and Co-President and COO of JPMorganChase. He was appointed sole President and COO in 2022.

Pinto holds a bachelor's degree in Public Accounting and Business Administration from Universidad Nacional de Lomas de Zamora in Buenos Aires and currently serves on the Board of Directors of the Institute of International Finance.

For more information, visit www.jnj.com.

Source: Johnson & Johnson